| The latest issue of the BIG Research in Focus is now available! |
|
This edition of the multi-part BIG Research in Focus series entitled “Fighting breast cancer around the globe” is dedicated to breast cancer research in Western Europe. Breast cancer research groups in Western Europe were among the first to join BIG when it was founded in 1999. Today, they recognise the advantages of a major international research organisation in reducing fragmentation of effort and avoiding duplication. However, escalating clinical trial costs, slower access to novel therapies, COVID-19 and even a major cyber-attack on a national healthcare computer system have been among recent challenges reported by leading oncologists from these groups. With the themed article on Western Europe, we are closing the series “Fighting Breast Cancer Around the Globe”. We have now covered all the regions represented by BIG’s group members. BIG would like to thank everyone who accepted to be interviewed. In the last five years, about 50 breast cancer experts from the BIG network, representing nearly 40 countries, have shared with us their valuable insights into major developments in breast cancer care and research that are improving the outlook for patients around the world. The section “BIG Network” provides an overview of activities carried out by BIG Headquarters (HQ) and includes news from BIG members. At the virtual General Assembly of last June, two new academic cancer research groups were accepted as members of BIG. We are pleased to welcome the European Breast Cancer Research Association of Surgical Trialists (EUBREAST) Network, which consists of the German association EUBREAST e.V. and its Italian counterpart EUBREAST ETS. Other news: On 11 June, the newly elected Executive Board was presented to BIG’s General Assembly. BIG against breast cancer, BIG’s dedicated philanthropy unit within BIG HQ, conducts vital fundraising to support BIG’s clinical trials and research programmes that have no commercial interest but are crucial for breast cancer patients. The funds raised – through the generosity of foundations, companies, ambassadors, and other individuals – contribute to the work of BIG member groups and their affiliated hospitals and help support patient participation in a study. In the section “Clinical Trials and Activities”, we include an interview of Prof Martine Piccart and Dr Philippe Aftimos, who provide us with their insights and an update on the AURORA programme on metastatic breast cancer. We also include an update on the OlympiA clinical trial. The section “Other trials and activities by BIG Member Groups” gives a peek at BIG member’s research and related activities around the world. Finally, an overview of all the clinical studies and trials run within the BIG network is provided. As always, many thanks to the BIG Member Groups for their precious contributions and their help in compiling the BIG Research in Focus.
We hope you will enjoy the reading! |
|
Copyright © 2021 Breast International Group (BIG), All rights reserved.
Please note: You are receiving this message because you are a member or supporter of BIG or because you subscribed to receive our newsletter by email. You can unsubscribe at any time by informing us via [email protected]. |
|
|
|
|
|
|
